|
1
|
Thurnher MM: 2007 World Health
Organization classification of tumours of the central nervous
system. Cancer Imaging. 9(Special Issue A): S1–S3. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth following chemotherapy. Nature. 488:522–526.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen R, Nishimura MC, Bumbaca SM,
Kharbanda S, Forrest WF, Kasman IM, Greve JM, Soriano RH, Gilmour
LL, Rivers CS, et al: A hierarchy of self-renewing tumor-initiating
cell types in glioblastoma. Cancer Cell. 17:362–375. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gillet JP, Calcagno AM, Varma S, Marino M,
Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, et al:
Redefining the relevance of established cancer cell lines to the
study of mechanisms of clinical anti-cancer drug resistance. Proc
Natl Acad Sci USA. 108:18708–18713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su
Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, et al:
Tumor stem cells derived from glioblastomas cultured in bFGF and
EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. Cancer Cell. 9:391–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang X, Ketova T, Litingtung Y and Chiang
C: Isolation, enrichment, and maintenance of medulloblastoma stem
cells. J Vis Exp. 2086:2010.
|
|
9
|
Favaro R, Appolloni I, Pellegatta S, Sanga
AB, Pagella P, Gambini E, Pisati F, Ottolenghi S, Foti M,
Finocchiaro G, et al: Sox2 is required to maintain cancer stem
cells in a mouse model of high-grade oligodendroglioma. Cancer Res.
74:1833–1844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reynolds BA and Rietze RL: Neural stem
cells and neurospheres-re-evaluating the relationship. Nat Methods.
2:333–336. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singec I, Knoth R, Meyer RP, Maciaczyk J,
Volk B, Nikkhah G, Frotscher M and Snyder EY: Defining the actual
sensitivity and specificity of the neurosphere assay in stem cell
biology. Nat Methods. 3:801–806. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suslov ON, Kukekov VG, Ignatova TN and
Steindler DA: Neural stem cell heterogeneity demonstrated by
molecular phenotyping of clonal neurospheres. Proc Natl Acad Sci
USA. 99:14506–14511. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balvers RK, Kleijn A, Kloezeman JJ, French
PJ, Kremer A, van den Bent MJ, Dirven CM, Leenstra S and Lamfers
ML: Serum-free culture success of glial tumors is related to
specific molecular profiles and expression of extracellular
matrix-associated gene modules. Neuro Oncol. 15:1684–1695. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fael A, l-Mayhani TM, Ball SL, Zhao JW,
Fawcett J, Ichimura K, Collins PV and Watts C: An efficient method
for derivation and propagation of glioblastoma cell lines that
conserves the molecular profile of their original tumours. J
Neurosci Methods. 176:192–199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pollard SM, Yoshikawa K, Clarke ID, Danovi
D, Stricker S, Russell R, Bayani J, Head R, Lee M, Bernstein M, et
al: Glioma stem cell lines expanded in adherent culture have
tumor-specific phenotypes and are suitable for chemical and genetic
screens. Cell Stem Cell. 4:568–580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of Tumors of the Central Nervous System: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma YH, Mentlein R, Knerlich F, Kruse ML,
Mehdorn HM and Held-Feindt J: Expression of stem cell markers in
human astrocytomas of different WHO grades. J Neurooncol. 86:31–45.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pallini R, Ricci-Vitiani L, Montano N,
Mollinari C, Biffoni M, Cenci T, Pierconti F, Martini M, De Maria R
and Larocca LM: Expression of the stem cell marker CD133 in
recurrent glioblastoma and its value for prognosis. Cancer.
117:162–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He J, Shan Z, Li L, Liu F, Liu Z, Song M
and Zhu H: Expression of glioma stem cell marker CD133 and
O6-methylguanine-DNA methyltransferase is associated with
resistance to radiotherapy in gliomas. Oncol Rep. 26:1305–1313.
2011.PubMed/NCBI
|
|
20
|
Shin JH, Lee YS, Hong YK and Kang CS:
Correlation between the prognostic value and the expression of the
stem cell marker CD133 and isocitrate dehydrogenase1 in
glioblastomas. J Neurooncol. 115:333–341. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brescia P, Ortensi B, Fornasari L, Levi D,
Broggi G and Pelicci G: CD133 is essential for glioblastoma stem
cell maintenance. Stem Cells. 31:857–869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maucksch C, Jones KS and Connor B: Concise
review: The involvement of SOX2 in direct reprogramming of induced
neural stem/precursor cells. Stem Cells Transl Med. 2:579–583.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Z, Chi L, Fang Y, Liu L and Zhang X:
Specific expression pattern of a novel Otx2 splicing variant during
neural differentiation. Gene. 523:33–38. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang X, Huang CT, Chen J, Pankratz MT, Xi
J, Li J, Yang Y, Lavaute TM, Li XJ, Ayala M, et al: Pax6 is a human
neuroectoderm cell fate determinant. Cell Stem Cell. 7:90–100.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Berezovsky AD, Poisson LM, Cherba D, Webb
CP, Transou AD, Lemke NW, Hong X, Hasselbach LA, Irtenkauf SM,
Mikkelsen T and deCarvalho AC: Sox2 promotes malignancy in
glioblastoma by regulating plasticity and astrocytic
differentiation. Neoplasia. 16:193–206.e25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ellis P, Fagan BM, Magness ST, Hutton S,
Taranova O, Hayashi S, McMahon A, Rao M and Pevny L: SOX2, a
persistent marker for multipotential neural stem cells derived from
embryonic stem cells, the embryo or the adult. Dev Neurosci.
26:148–165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oppel F, Müller N, Schackert G, Hendruschk
S, Martin D, Geiger KD and Temme A: SOX2-RNAi attenuates S-phase
entry and induces RhoA-dependent switch to protease-independent
amoeboid migration in human glioma cells. Mol Cancer. 10:1372011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alonso MM, Diez-Valle R, Manterola L,
Rubio A, Liu D, Cortes-Santiago N, Urquiza L, Jauregi P, Lopez de
Munain A, Sampron N, et al: Genetic and epigenetic modifications of
Sox2 contribute to the invasive phenotype of malignant gliomas.
PLoS One. 6:e267402011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fang X, Yoon JG, Li L, Yu W, Shao J, Hua
D, Zheng S, Hood L, Goodlett DR, Foltz G and Lin B: The SOX2
response program in glioblastoma multiforme: An integrated
ChIP-seq, expression microarray, and microRNA analysis. BMC
Genomics. 12:112011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cox JL, Wilder PJ, Desler M and Rizzino A:
Elevating SOX2 levels deleteriously affects the growth of
medulloblastoma and glioblastoma cells. PLoS One. 7:e440872012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Skalli O, Wilhelmsson U, Orndahl C, Fekete
B, Malmgren K, Rydenhag B and Pekny M: Astrocytoma grade IV
(glioblastoma multiforme) displays 3 subtypes with unique
expression profiles of intermediate filament proteins. Hum Pathol.
44:2081–2088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Irshad K, Mohapatra SK, Srivastava C, Garg
H, Mishra S, Dikshit B, Sarkar C, Gupta D, Chandra PS,
Chattopadhyay P, et al: A combined gene signature of hypoxia and
notch pathway in human glioblastoma and its prognostic relevance.
PLoS One. 10:e01182012015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kang TW, Choi SW, Yang SR, Shin TH, Kim
HS, Yu KR, Hong IS, Ro S, Cho JM and Kang KS: Growth arrest and
forced differentiation of human primary glioblastoma multiforme by
a novel small molecule. Sci Rep. 4:55462014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang XQ and Zhang SC: Differentiation of
neural precursors and dopaminergic neurons from human embryonic
stem cells. Methods Mol Biol. 584:355–366. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ,
Thomson JA and Zhang SC: Neural differentiation of human induced
pluripotent stem cells follows developmental principles but with
variable potency. Proc Natl Acad Sci USA. 107:4335–4340. 2010.
View Article : Google Scholar : PubMed/NCBI
|
